Cas:1220039-98-4 6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine manufacturer & supplier

We serve Chemical Name:6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine CAS:1220039-98-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine

Chemical Name:6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine
CAS.NO:1220039-98-4
Synonyms:6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine
Molecular Formula:C10H12FN
Molecular Weight:165.20700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.02000
Exact Mass:165.09500
LogP:2.86210

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine Use and application,6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine technical grade,usp/ep/jp grade.


Related News: Our pharma and biotech offering includes registration and commercialization of products through in-licensing and flexible partnerships. 6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine manufacturer The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured. 6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine supplier The Philippines reported its first Wuhan coronavirus fatality on Sunday. 6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine vendor The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 6-fluoro-1,2,3,4-tetrahydronaphthalen-1-amine factory The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.